Ali Saeed, MD
Internal Medicine · Cedar Rapids, IANPI 1073997045
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (54.7%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 77.6% of it on its own, with 30 other manufacturers making up the rest. Reporting peaked in 2023 at $10,926 and has fallen 92.0% since, to $875 in 2025. Among internal medicine clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 188 payments — averaging $88.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$13K
- AstraZeneca$803
- Boehringer Ingelheim$553
- GSK$396
- United Therapeutics Corporation$224
- Grifols USA, LLC$218
- plus $2K from 25 others
What the payments were for
- Travel & lodging$3,77723%
- Food & beverage$3,74623%
- Education$9,09555%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 29 | $12,902 |
| AstraZeneca | 31 | $803 |
| Boehringer Ingelheim | 28 | $553 |
| GSK | 25 | $396 |
| United Therapeutics Corporation | 9 | $224 |
| Grifols USA, LLC | 9 | $218 |
| Sanofi | 4 | $142 |
| Intercept Pharmaceuticals, Inc. | 1 | $128 |
| Jazz Pharmaceuticals Inc. | 3 | $117 |
| Regeneron Healthcare Solutions, Inc. | 5 | $114 |
| Harmony Biosciences LLC | 5 | $109 |
| AbbVie | 4 | $107 |
| Inspire Medical Systems, Inc. | 1 | $97 |
| Astellas Pharma US Inc | 2 | $88 |
| Amgen | 6 | $85 |
| Bayer | 4 | $83 |
| Merck | 3 | $71 |
| Baxter Healthcare | 2 | $45 |
| Actelion Pharmaceuticals US, Inc. | 2 | $43 |
| Pfizer | 2 | $42 |
| Philips North America LLC | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $34 |
| Conmed Corporation | 1 | $33 |
| Johnson & Johnson | 1 | $27 |
| Viatris Specialty LLC | 1 | $21 |
| La Jolla Pharmaceutical Company | 1 | $20 |
| Verona Pharma, Inc. | 1 | $20 |
| ERBE USA Inc | 1 | $16 |
| Inogen, Inc. | 2 | $15 |
| Electromed, Inc. | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$12,522
- OCALIVA$128
How this compares
$16,618 in reported general payments places this provider in the 95th percentile of 583 internal medicine providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 230 | $166,845 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 212 | $110,872 |
| Breo ElliptaFluticasone/Vilanterol | 116 | $52,359 |
| Advair HfaFluticasone Propion/Salmeterol | 55 | $18,407 |
| Incruse ElliptaUmeclidinium Bromide | 48 | $18,021 |
| Spiriva RespimatTiotropium Bromide | 27 | $14,103 |
| Spiriva HandihalerTiotropium Bromide | 21 | $11,478 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 14 | $10,747 |
| SymbicortBudesonide/Formoterol Fumarate | 33 | $9,763 |
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 17 | $8,149 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 16 | $7,478 |
| Varenicline Tartrate | 16 | $6,184 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 32 | $5,058 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 21 | $3,179 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 115 | $3,152 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Incruse Ellipta | $396 | $348,096606 claims |
| AstraZenecaBreztri Aerosphere, Symbicort, Bevespi Aerosphere | $803 | $28,66064 claims |
| Boehringer IngelheimSpiriva Respimat, Stiolto Respimat | $553 | $21,58143 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 583 internal medicine providers in Iowa.
Other internal medicine in Cedar Rapids
- Rezwan MunshiCedar Rapids$9K
- Fadi YacoubCedar Rapids$7K
- Susan SchimaCedar Rapids$1K
- Mark JohnsonMason City$223K
- Mark CarlsonSioux City$174K
- Madalyn WalshIowa City$80K
- Alan KricsfeldCouncil Bluffs$49K
- Aziz HammoudIowa City$29K
- Matthew FryzekCouncil Bluffs$28K
- Diana Rabadi MararCouncil Bluffs$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.